Lymphoma, T-Cell, Peripheral: all 607 studies
Page 6 of 7. Open to participants first (133), then studies with results posted, then the rest; newest registration first within each.
- A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in KoreaCompletedNCT01689220Phase 1
- Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell LymphomaCompletedNCT01679860Phase 2
- Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell LymphomaStatus unknownNCT01667302Phase 2
- Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell LymphomaTerminatedNCT01667289Phase 2
- Gemcitabine in NK/T Cell LymphomaCompletedNCT01660568
- Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic MalignanciesCompletedNCT01658319Phase 1
- Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesWithdrawnNCT01652014Phase 2
- Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis FungoidesStatus unknownNCT01645293Phase 1
- Phase 1b Safety and Efficacy Study of TRU-016TerminatedNCT01644253Phase 1
- Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)CompletedNCT01611142Phase 2
- Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell LymphomaCompletedNCT01590732Phase 1
- Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell TransplantCompletedNCT01588015Phase 1
- Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell LymphomaCompletedNCT01569724Phase 4
- Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaCompletedNCT01567709Phase 1
- Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)CompletedNCT01553786Phase 2
- Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid MalignanciesCompletedNCT01523223Phase 1
- Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/ⅣStatus unknownNCT01501149Phase 4
- Treatment of Natural Killer/T Cell Lymphoma-I/IIStatus unknownNCT01501136Phase 4
- A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell LymphomaCompletedNCT01486277Phase 2
- Clinical Usefulness and Prognostic Significance of Interim 18F-FDG PET/CT for the Treatment of Peripheral T Cell LymphomasStatus unknownNCT01470066
- Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis TreatmentCompletedNCT01460914
- Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell LymphomaTerminatedNCT01445340Phase 1
- A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL)CompletedNCT01435863Phase 1
- Trial of Endostar Combined With CHOPT for T Cell LymphomaStatus unknownNCT01430013Phase 2
- A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell LymphomaWithdrawnNCT01355783Phase 3
- Retrospective Analysis of Skin/Soft Tissue Primary NK/T Cell LymphomaCompletedNCT01341119
- Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell LymphomaCompletedNCT01336920Phase 1
- A Study of Escalating Doses of Romidepsin in Association With CHOP in the Treatment of Peripheral T-Cell LymphomasCompletedNCT01280526Phase 1/2
- Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancersCompletedNCT01254578Phase 1
- Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell LymphomaCompletedNCT01238159Phase 2
- RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell LymphomasCompletedNCT01198665Phase 1/2
- High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaCompletedNCT01177371Phase 2
- A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell LymphomaCompletedNCT01169298Phase 1
- RO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsCompletedNCT01158274Phase 1
- Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host DiseaseCompletedNCT01155817Phase 1
- T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell LymphomaCompletedNCT01142674
- Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaCompletedNCT01134341Phase 1
- Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell LymphomaStatus unknownNCT01132989Phase 2
- AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or LymphomaCompletedNCT01129193Phase 1
- Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell LymphomaCompletedNCT01129180Phase 1
- Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin LymphomaTerminatedNCT01116154Phase 1
- Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment RegistryCompletedNCT01110733
- Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for CancerCompletedNCT01053494Not applicable
- Study of Lenalidomide (Revlimid) in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL) PatientsTerminatedNCT01036399Phase 2
- Endostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell LymphomaStatus unknownNCT00974324Phase 2
- Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell LymphomaCompletedNCT00970385Phase 3
- Trial of Curcumin in Cutaneous T-cell Lymphoma PatientsWithdrawnNCT00969085Phase 2
- Bendamustine in Patients With Refractory or Relapsed T-cell LymphomaCompletedNCT00959686Phase 2
- Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or LeukemiaTerminatedNCT00933985Phase 1
- New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell LymphomaStatus unknownNCT00933673Phase 2
- The Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL)CompletedNCT00930605Phase 2
- Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell LymphomaCompletedNCT00901147Phase 2
- Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryCompletedNCT00891072Phase 1
- Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyCompletedNCT00890747Phase 1
- Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell LymphomaTerminatedNCT00880867Phase 1
- HuMax-CD4 in Non-Cutaneous T-Cell LymphomaCompletedNCT00877656Phase 2/3
- Recalcitrant Pruritus in Cutaneous T-Cell LymphomaTerminatedNCT00863395Phase 1/2
- Orally Fludarabine, Adriamycin and Dexamethasone (FAD) in Newly Diagnosed Peripheral T-cell Lymphomas (PTCL)Status unknownNCT00840385Phase 2
- A Nordic Phase II Study of PTCL Based on Dose-intensive Induction and High-dose Consolidation With ASCTCompletedNCT00791947Phase 2
- Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective StudyStatus unknownNCT00779896Phase 1/2
- FAU in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00769288Phase 1
- Observational Study on the Occurrence of Hepatosplenic T-cell Lymphoma in Patients of NetherlandsCompletedNCT00731536
- Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOPStatus unknownNCT00725231Phase 3
- T-Cell Project: Epidemiologic ComponentCompletedNCT00705809
- Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell LymphomasTerminatedNCT00704691Early Phase 1
- Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/LymphomaTerminatedNCT00699296Phase 2
- Alemtuzumab and CHOP in T-cell LymphomaCompletedNCT00646854Phase 3
- A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)CompletedNCT00611208Phase 2
- Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT00608361Phase 1
- Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell LymphomaStatus unknownNCT00562068Phase 1
- Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaCompletedNCT00554827Phase 1
- Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic MalignanciesTerminatedNCT00514722Not applicable
- Forodesine in the Treatment of Cutaneous T-Cell LymphomaCompletedNCT00501735Phase 2
- Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver DysfunctionCompletedNCT00499811Phase 1
- A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell LymphomaTerminatedNCT00476554Phase 2
- Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaCompletedNCT00458731Phase 1
- Alemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell LymphomasCompletedNCT00453427Phase 1/2
- The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCLTerminatedNCT00441025Phase 2
- A Study of APO866 for the Treatment of Cutaneous T-cell LymphomaCompletedNCT00431912Phase 2
- Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow CancersTerminatedNCT00421213Phase 2
- LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell LymphomaCompletedNCT00412997Phase 1
- A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid MalignanciesCompletedNCT00406809Phase 1/2
- Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell LymphomasCompletedNCT00374699Phase 1/2
- PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or LymphomaTerminatedNCT00354185Phase 1
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic MalignanciesCompletedNCT00343798Phase 1
- A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's LymphomaCompletedNCT00322985Phase 2
- Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell LymphomaCompletedNCT00306969Phase 1/2
- A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Depsipeptide (FK228) in Patients That Have Completed a Prior Clinical Study With Depsipeptide.Status unknownNCT00299351Phase 2
- Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell LymphomaCompletedNCT00283985Phase 2
- Effect of Denileukin Diftitox on Immune System in CTCL PatientsCompletedNCT00254332
- Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2ACompletedNCT00221039Phase 4
- Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)CompletedNCT00211198Phase 4
- In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)CompletedNCT00177190
- LAMPP Trial for Peripheral and Cutaneous T-Cell LymphomaTerminatedNCT00161239Not applicable
- Study of Bortezomib Combined With ACVBP in Peripheral T-cell LymphomaCompletedNCT00136565Phase 2
- Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaTerminatedNCT00101205Phase 1
- Immunization Against Tumor Cells in Sezary SyndromeCompletedNCT00099593Phase 2
- Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)CompletedNCT00091559Phase 2
- Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantCompletedNCT00078858Phase 1/2
- Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.CompletedNCT00071084Phase 2